Eosinophilic Gastrointestinal Disorders Patient Registry

NCT01779154 | Withdrawn

• 1 other identifier: 136132
• Study Type: observational
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The Eosinophilic Gastrointestinal Disorders (EGIDS) Registry is a longitudinal study that does not involve medical interventions, but serves as a record of demographics, characteristics of disease and treatment, utilization patterns, quality improvement measures and clinical outcomes. The database is proposed so that epidemiologic research can be performed and current and accurate data can be obtained regarding practice patterns, age and gender distributions, efficacy of treatment, clinical outcomes and changes in quality of life.

Conditions

Eosinophilic Esophagitis; Eosinophilic Gastritis; Eosinophilic Enteritis; Eosinophilic Colitis

Keywords

eosinophilic esophagitis; eosinophilic gastritis; eosinophilic enteritis; eosinophilic colitis

Outcome Measures

Primary Outcomes (1)

• To define characteristics of an eosinophilic gastrointestinal disorder population in a rural southern state

  To develop a database of patients with eosinophilic gastrointestinal disorders so that epidemiologic research can be performed and current data can be obtained regarding practice patterns, age and gender distributions, efficacy of treatment, clinical outcomes and changes in quality of life.

  After 12 months of data collection

Study Arms (1)

eosinophilic gastrointestinal disorders

Individuals with a diagnosis of EGID including: eosinophilic esophagitis, eosinophilic gastritis, eosinophilic enteritis, eosinophilic colitis

Eligibility Criteria

• Age: Up to 21 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Individuals with a diagnosis of an eosinophilic gastrointestinal disorder

You may qualify if:

• male or female participants of any race or ethnicity
• age 0 to 21 years
• diagnosis of EGID including: eosinophilic esophagitis, eosinophilic gastritis, eosinophilic enteritis, eosinophilic colitis

You may not qualify if:

• hypereosinophilic syndrome
• non-eosinophilic gastrointestinal or allergic disorder

Sponsors & Collaborators

• Arkansas Children's Hospital Research Institute: lead

Study Sites (1)

Arkansas Children's Hospital

Little Rock, Arkansas, 72202, United States

Location

Related Publications (1)

• Pesek RD, Rettiganti M, O'Brien E, Beckwith S, Daniel C, Luo C, Scurlock AM, Chandler P, Levy RA, Perry TT, Kennedy JL, Chervinskiy S, Vonlanthen M, Casteel H, Fiedorek SC, Gibbons T, Jones SM. Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2017 Aug;119(2):177-183. doi: 10.1016/j.anai.2017.06.006. Epub 2017 Jul 1.

  PMID: 28676207 DERIVED

MeSH Terms

Conditions

Eosinophilic Esophagitis; Eosinophilic enteropathy

Condition Hierarchy (Ancestors)

Esophagitis; Esophageal Diseases; Gastrointestinal Diseases; Digestive System Diseases; Gastroenteritis; Eosinophilia; Leukocyte Disorders; Hematologic Diseases; Hemic and Lymphatic Diseases; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Officials

• Robbie D Pesek, MD

  University of Arkansas for Medical Sciences / Arkansas Children's Hospital Research Institute

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 21 Years
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 28, 2013
• First Posted: January 30, 2013
• Study Start: January 1, 2013
• Primary Completion: May 1, 2016
• Study Completion: May 1, 2017
• Last Updated: June 20, 2016

Record last verified: 2016-06

Locations

US (1)